# Testosterone in Bariatric Patients

> **NCT03721497** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Esbjerg Hospital - University Hospital of Southern Denmark** · enrollment: 64 (actual)

## Conditions studied

- Bariatric Surgery Candidate
- Male Hypogonadism
- Muscle Loss

## Interventions

- **DRUG:** Testosterone Undecanoate

## Key facts

- **NCT ID:** NCT03721497
- **Lead sponsor:** Esbjerg Hospital - University Hospital of Southern Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-17
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03721497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03721497, "Testosterone in Bariatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03721497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*